Skip to main content

Chemical Entities of Biological Interest Ontology (CHEBI)

Search from vocabulary

align
annotate
download

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organonitrogen compound > organonitrogen heterocyclic compound > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organonitrogen heterocyclic compound > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > monocyclic compound > heteromonocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > heteromonocyclic compound > organic heteromonocyclic compound > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > oxacycle > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > oxacycle > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > oxacycle > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > oxacycle > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > oxacycle > oxazinane > morpholines > N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide

Preferred term

N-(4-{(2r,3r)-3-(hydroxymethyl)-4-[(1-methyl-1h-imidazol-2-yl)methyl]-5-oxo-2-morpholinyl}phenyl)-2-methylpropanamide  

Broader concept

Synonym(s)

  • N-[4-[(2R,3R)-3-(hydroxymethyl)-4-[(1-methylimidazol-2-yl)methyl]-5-oxomorpholin-2-yl]phenyl]-2-methylpropanamide

Belongs to group

URI

http://data.loterre.fr/ark:/67375/KFP-MGJ35R5V-3

Download this concept:

RDF/XML TURTLE JSON-LD